Gp100 adenoviral gene therapy

Gp100 adenoviral gene therapy
Trade Name
Orphan Indication Metastatic melanoma
USA Market Approval USA
USA Designation Date 1997-03-25 00:00:00
Sponsor Genzyme Corporation;500 Kendall Street;Cambridge, Massachusetts, 02142